60 Degrees Pharmaceuticals, Inc.
SXTP
$1.44
$0.02121.49%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.82M | -10.25M | -7.95M | -7.91M | -1.57M |
| Total Depreciation and Amortization | 67.10K | 58.40K | 63.70K | 71.20K | 81.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | 0.00 | 27.30K |
| Total Other Non-Cash Items | 1.30M | 3.83M | 2.04M | 2.49M | -3.70M |
| Change in Net Operating Assets | 82.50K | 257.60K | 192.60K | 1.28M | -984.00K |
| Cash from Operations | -6.37M | -6.11M | -5.65M | -4.07M | -6.15M |
| Capital Expenditure | -63.80K | -106.50K | -103.80K | -159.60K | -147.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -34.20K | -70.40K | -1.79M | -1.79M | -87.30K |
| Cash from Investing | -97.90K | -176.80K | -1.89M | -1.95M | -234.90K |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | -- | 0.00 | -1.61M |
| Issuance of Common Stock | 6.95M | 6.95M | 7.14M | 7.14M | 9.49M |
| Repurchase of Common Stock | -119.10K | -119.10K | -101.10K | -150.40K | -150.40K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 22.10K | 16.20K | 16.20K | 64.50K | 140.60K |
| Cash from Financing | 6.85M | 6.85M | 7.05M | 7.05M | 7.87M |
| Foreign Exchange rate Adjustments | 7.10K | -8.60K | 500.00 | 56.70K | 64.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 390.30K | 556.80K | -483.10K | 1.08M | 1.56M |